Objective The main objective of this study is to assess the efficacy of mesenchymal stemcell therapy for the management of chronic stroke Methods In this randomized control trial patients were placed in two groups who received intravenous injections of autologous mesenchymal stem cells at the same time placebos were also given to the patients. The clinical and neurological parameters of the patients were measured before and after the completion of the treatment. Results The results of the study revealed that mesenchymal stem cells were infused among the patients with a mean of 4.49 × 107. The patients didn’t experience any adverse effects pre and post-treatment. Glasgow outcome scale showed some significant clinical improvement in receiving mesenchymal stem cell therapy as compared to placebo. Conclusion Mesenchymal stem cell therapy is safe to use as it helps to improve the condition of stroke along with neurological conditions.

Cell therapy, chronic, mesenchymal stem cells, stroke